Reverse remodelling in heart failure with cardiac resynchronisation therapy

Heart

Volumn 93, Issue 2, 2007, Pages 167-171

  St John Sutton, M ^a   Keane, M G ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE RECEPTOR BLOCKING AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; CARDIOVASCULAR AGENT; CATECHOLAMINE DERIVATIVE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDRALAZINE; NITRIC ACID DERIVATIVE; PHOSPHODIESTERASE INHIBITOR; UNCLASSIFIED DRUG;

CARDIAC RESYNCHRONIZATION THERAPY; DIASTOLE; DISEASE SEVERITY; GENETIC DISORDER; HEART CONTRACTION; HEART DILATATION; HEART INFARCTION; HEART VENTRICLE OVERLOAD; HEART VENTRICLE REMODELING; HUMAN; IMAGING SYSTEM; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; REVIEW; SYSTOLIC HEART FAILURE; TREATMENT OUTCOME;

CARDIAC PACING, ARTIFICIAL; ELECTRIC COUNTERSHOCK; EXERCISE TOLERANCE; HEART FAILURE, CONGESTIVE; HUMANS; MYOCARDIAL CONTRACTION; RANDOMIZED CONTROLLED TRIALS; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 33846604229     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.2005.067967     Document Type: Review

References (25)

1. American Heart Association. 2001 heart and stroke statistical update. Dallas, TX: American Heart Association, 2000.
2. Vasan RS, Benjamin EJ, Levy D. Prevalence, clinical features and prognosis of diastolic heart failure: an epidemiologic perspective. J Am Coll Cardiol 1995;26:1505-74.
3. Nohria A, Lewis E, Stevenson LW. Medical management of advanced heart failure. JAMA 2002;287:628-40.
4. Hunt SA, Baker DW, Chin MH, et al. ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (committee to revise the 1995 guidelines for the evaluation and management of heart failure). Circulation 2001;104:2996-3007.
5. Stellbrink C, Breithardt O, Franke A, et al. Impact of cardiac resynchronization therapy using hemodynamically optimized pacing on left ventricular remodeling in patients with congestive heart failure and ventricular conduction disturbances. J Am Coll Cardiol 2001;38:1957-05.
6. Abraham WT, Fisher WG, Smith AL, et al. Cardiac resynchronization in chronic heart failure. N Engl J Med 2002;346:1845-53.
7. Cazeau S, Leclercq C, Lavergne T, et al. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med 2001;344:873-80.
8. Shamin W, Francis DP, Yousufuddin M, et al. Intraventricular conduction delay: a prognostic marker in chronic heart failure. Int J Cardiol 1999;31:171-8.
9. St. John Sutton M, Lee D, Rouleau JL, et al. Left ventricular remodeling and ventricular arrhythmias after myocardial infarction. Circulation 2003;107:2577-82.
10. Bristow MR, Saxon LA, Boehmer J, et al. Cardiac resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004;350:2140-50.
11. Moss AJ, Zareba W, Hall WJ, for the Multicenter Automatic Defibrillator Implantation Trial II Investigators, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002;346:877-83.
12. Messenger J, Kruger K, Hilpisch KE, et al. Effect of cardiac resynchronization therapy on left ventricular size and function in chronic heart failure. Circulation 2003;107:1985-90.
13. Cleland JGF, Daubert JC, Erdmann E, et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005;352:1539-49.
14. Linde C, Leclercq C, Rex S, et al. Long-term benefits of biventricular pacing in congestive heart failure: results from the Multisite Stimulation in Cardiomyopathy (MUSTIC) study. J Am Coll Cardiol 2002;40:111-18.
15. Molhoek SG, Bax JJ, van Erven L, et al. Comparison of benefits from cardiac resynchronization therapy in patients with ischemic cardiomyopathy versus idiopathic dilated cardiomyopathy. Am J Cardiol 2004;93:860-3.
16. Chuang ML, Hibberd MG, Salton CJ, et al. Importance of imaging method over imaging modality in noninvasive determination of left ventricular volumes and ejection fraction: assessment by two- and three-dimensional echocardiography and magnetic resonance imaging. J Am Coll Cardio 2000;35:477-84.
17. Burns RJ, Gibbons RJ, Yi Q, et al. The relationship of left ventricular ejection fraction, end systolic volume index and infarct size to six-month mortality after hospital discharge following myocardial infarction treated by thrombolysis. J Am Coll Cardiol 2002;39:30-6.
18. St John Sutton M, Pfeffer MA, Plappert T, et al. Quantitative two-dimensional echocardiographic measurments are major predictors of adverse cardiovascular events after acute myocardial infarction. The protective effects of captopril. Circulation 1994;89:68-75.
19. Abraham WT, Leon AR, Young JB. Benefits of cardiac resynchronization therapy sustained for 18 months: results from the MIRACLE program [abstract]. Circulation 2003;108(Suppl IV):IV-629.
20. Young JB, Abraham WT, Smith AL, et al. Multicenter InSync ICD Randomized Clinical Evaluation (MIRACLE ICD) trial investigators. Combined cardiac resynchronization and implantable cardioverter defibrillation in advanced chronic heart failure. The MIRACLE ICD trial. JAMA 2003;289:2865-694.
21. St John Sutton M, Plappert T, Hilpisch KE, et al. Sustained reverse left ventricular structural remodeling with cardiac resynchronization at one year is a function of etiology. Circulation 2006;113:266- 72.
22. Yu CM, Chau E, Sanderson JE, et al. Tissue Doppler echoardiographic evidence of reverse remodeling and improved synchronicity by simultaneously delaying regional contraction after biventricular pacing therapy in heart failure. Circulation 2002;105:438-45.
23. Kanzaki H, Bazaz R, Schwartzman D, et al. A mechanism for immediate reduction in mitral regurgitation after cardiac resynchronization therapy: insights from mechanical activation strain mapping. J Am Coll Cardiol 2004;44:1619-25.
24. Bax JJ, Abraham T, Barold SS, et al. Cardiac resynchronization therapy. Part 1. Issues before device implantation. J Am Coll Cardiol 2005;45:2153-67.
25. Bax JJ, Abraham T, Barold SS, et al. Cardiac resynchronization therapy. Part 2. Issues during and after device implantation and unresolved questions. J Am Coll Cardiol 2005;46:2168-82.